Clinical Trial Information
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's- Protocol Number: 10600
- Status: Open
- Treatment Type: Treatment
- Secondary Protocol No.: RPC01-3201
- Phase: III
- NCT ID: NCT03440372
Scope Information
- Disease Site(s):
- Other